Cargando…

Tumour suppressor genes in chemotherapeutic drug response

Since cancer is one of the leading causes of death worldwide, there is an urgent need to find better treatments. Currently, the use of chemotherapeutics remains the predominant option for cancer therapy. However, one of the major obstacles for successful cancer therapy using these chemotherapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Dulcie, Visser-Grieve, Stacy, Yang, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392105/ https://www.ncbi.nlm.nih.gov/pubmed/22762204 http://dx.doi.org/10.1042/BSR20110125

Ejemplares similares

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET
por: Schneider-Kolsky, Michal E, et al.
Publicado: (2010)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs
por: Mellor, H R, et al.
Publicado: (2005)

Chemotherapeutic Drugs Interfere with Gene Delivery Mediated by Chitosan-Graft-Poly(ethylenimine)
por: Lai, Wing-Fu, et al.
Publicado: (2015)

ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021)

Genetic Systems to Investigate Regulation of Oncogenes and Tumour Suppressor Genes in Drosophila
por: Lee, Jue Er Amanda, et al.
Publicado: (2012)

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
por: Ng, Jennifer Mun-Kar, et al.
Publicado: (2015)

The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts
por: Tourell, Monique C., et al.
Publicado: (2017)

Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015)

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
por: Kersten, Kelly, et al.
Publicado: (2015)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Ionic Interpretation of Drug Action in Chemotherapeutic Research
Publicado: (1956)

Is DNA methylation of tumour suppressor genes epigenetic?
por: Struhl, Kevin
Publicado: (2014)

TUSC3: a novel tumour suppressor gene and its functional implications
por: Yu, Xinshuang, et al.
Publicado: (2017)

Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer
por: Morgan, Richard, et al.
Publicado: (2022)

Predicting chemotherapeutic drug combinations through gene network profiling
por: Nguyen, Thi Thuy Trang, et al.
Publicado: (2016)

The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents
por: Gravett, Andrew M., et al.
Publicado: (2020)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
por: Braidwood, Lynne, et al.
Publicado: (2013)

Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
por: Lambert, Ian Henry, et al.
Publicado: (2018)

Proceedings: The response to chemotherapeutic agents of mouse tumour cells in the exponential and stationary phases of growth.
por: Twentyman, P. R., et al.
Publicado: (1974)

Antibody–drug conjugates as novel anti-cancer chemotherapeutics
por: Peters, Christina, et al.
Publicado: (2015)

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
por: Burmi, Rajpal S., et al.
Publicado: (2022)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
por: Wang, Chun-I, et al.
Publicado: (2021)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
por: Triarico, Silvia, et al.
Publicado: (2019)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)

Tumour Suppressor Genes—One Hit Can Be Enough
por: Hohenstein, Peter
Publicado: (2004)

Characterisation of the tumour suppressor gene ZAC in breast tissue
por: Valleley, EM, et al.
Publicado: (2006)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Multiphysics and Multiscale Analysis for Chemotherapeutic Drug
por: Zhang, Linan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4er8qcqv3ll1l3bjcb91iev8tj